Progress in Re-differentiating Therapy of Radioiodine-refractory Differentiated Thyroid Cancer
The majority patients of differentiated thyroid carcinoma (DTC) with indolent progression have general good prognosis after standard primary treatments including surgery, thyroid stimulating hormone (TSH) suppression and radioactive iodine (RAI) therapy. However, there are still some patients suffer...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Chinês |
| Pubblicazione: |
Magazine House of Cancer Research on Prevention and Treatment
2022-10-01
|
| Serie: | Zhongliu Fangzhi Yanjiu |
| Soggetti: | |
| Accesso online: | http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.22.0011 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|